Universal Insurance (UVE) Form 144: Proposed 20,000-Share Sale via Raymond James

Rhea-AI Filing Summary

Universal Insurance Hldg, Inc. (UVE) filer submitted a Form 144 reporting proposed and recent sales of common stock by an individual identified as Sean Downes. The notice lists a proposed sale of 20,000 shares through Raymond James & Associates with an aggregate market value of $465,000 and an approximate sale date of 09/04/2025 on the NYSE. The securities were reported as acquired on 08/12/2025 as "in lieu compensation" from the issuer, with payment noted as cash. The filing also discloses three sales in the past three months totaling 70,000 shares on 06/12/2025, 06/13/2025, and 08/04/2025 with gross proceeds of $671,524.05, $660,619.05, and $462,794.05 respectively. The signer certifies no undisclosed material adverse information.

Positive

• Transparent disclosure of proposed sale: broker named (Raymond James) and exchange specified (NYSE)
• Detailed transaction history for the past three months with dates and gross proceeds provided

Negative

• Insider sales volume in the past three months totals 70,000 shares, indicating significant insider liquidity
• Proposed additional sale of 20,000 shares scheduled for 09/04/2025

Insights

Securities Analyst

TL;DR: Form 144 discloses insider sales totaling 70,000 shares recently and a proposed 20,000-share sale; transaction dates and proceeds are specified.

The filing provides clear, transaction-level disclosure: an upcoming sale of 20,000 shares via Raymond James valued at $465,000 and three prior sales in the past three months aggregating 70,000 shares with stated gross proceeds. The acquisition entry showing 20,000 shares received as "in lieu compensation" on 08/12/2025 is documented with cash payment. For investors, the filing is a routine transparent disclosure of insider liquidity events rather than a corporate operational disclosure; it does not include operational performance metrics.

Compliance/Risk Analyst

TL;DR: Regulatory disclosure appears complete for Rule 144 purposes; signature attests to absence of undisclosed material adverse information.

The Form 144 includes required broker identification, share counts, aggregate market values, acquisition details, and recent sales history, supporting compliance with Rule 144 reporting. The signer’s attestation is present. The document does not include any additional compliance notes or trading-plan details. From a filings-compliance perspective, the notice meets the explicit content requirements stated within the form.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	20000	465000.00	28287000	09/04/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/12/2025	Lieu Compensation	Issuer			20000	08/12/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Sean Downes 800 Lake Dr Boca Raton FL 33432	Common	08/04/2025	20000	462794.05
Sean Downes 800 Lake Dr Boca Raton FL 33432	Common	06/12/2025	25000	671524.05
Sean Downes 800 Lake Dr Boca Raton FL 33432	Common	06/13/2025	25000	660619.05

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the UVE Form 144 disclose about planned sales?

The Form 144 discloses a proposed sale of 20,000 common shares via Raymond James with an aggregate market value of $465,000 and an approximate sale date of 09/04/2025 on the NYSE.

Who is the seller named in the UVE Form 144 filing?

The filing identifies Sean Downes as the person associated with recent sales and the account for the proposed sale.

What recent sales by the filer are reported in the Form 144?

Three sales in the past three months are reported: 25,000 shares on 06/12/2025 for $671,524.05, 25,000 shares on 06/13/2025 for $660,619.05, and 20,000 shares on 08/04/2025 for $462,794.05.

How were the 20,000 shares to be sold on 09/04/2025 acquired?

Those 20,000 shares are reported as acquired on 08/12/2025 as "in lieu compensation" from the issuer, with cash noted as the payment method.

Does the filing state any undisclosed material information about the issuer?

By signing the notice, the person represents they do not know any material adverse information regarding the issuer that has not been publicly disclosed.